Article Details

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update

Retrieved on: 2022-07-13 13:30:05

Tags for this article:

Click the tags to see associated articles and topics

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update. View article details on hiswai:

Excerpt

Fremont, CA - (NewMediaWire) - July 13, 2022 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing ...

Article found on: virtual-strategy.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up